FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

N/A Completed NCT05504811

Condition	Cognitive Dysfunction, Dementia, Mild
Phase	N/A
Sponsor	Flint Rehabilitation Devices, LLC
Status	Completed
Enrollment	31 participants
Interventions	FitMi AD, Conventional exercise program
Start date	Sep 8, 2023
Completion date	Mar 12, 2025
Results posted	Jul 20, 2026

Summary

This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.

Change in Functional Reach Test

Baseline, Immediately Post-Treatment (an average of 3 months) · centimeters

Experimental: FitMi AD Exercise Program	-0.21 ± 2.27 centimeters
Active Comparator: Conventional Booklet of Exercise Program	-0.16 ± 3.36 centimeters

p-value	0.96

Change in Timed Up and Go Test

Baseline, Immediately Post-Treatment (an average of 3 months) · Seconds

Experimental: FitMi AD Exercise Program	-0.50 ± 3.33 Seconds
Active Comparator: Conventional Booklet of Exercise Program	-1.05 ± 2.77 Seconds

p-value	0.63

Change in 30 Second Chair Stand Test

Baseline, Immediately Post-Treatment (an average of 3 months) · number of times the patient stands in 30

Experimental: FitMi AD Exercise Program	-0.07 ± 0.59 number of times the patient stands in 30
Active Comparator: Conventional Booklet of Exercise Program	-0.19 ± 0.53 number of times the patient stands in 30

p-value	0.59

Open in BENITIONS View on ClinicalTrials.gov

Other trials for this condition

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
Technology and Family Thriving Study — University of California, Santa Barbara
Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation

All trials

This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.

English 한국어 日本語中文 Русский